ACOG Form 4: Robert Wills Acquires 15,000 Shares in Open Market
Rhea-AI Filing Summary
Alpha Cognition director Robert Wills purchased 15,000 shares of common stock in open market transactions on 08/18/2025. The filing shows a weighted average price of $8.4885 per share, with individual trade prices ranging from $8.15 to $8.86. After the purchases the reporting person beneficially owns 15,000 shares. The Form 4 was filed by one reporting person and identifies the purchase as an open market acquisition; the filer agrees to provide transaction-level price details on request.
Positive
- Director Robert Wills executed an open-market purchase of 15,000 shares
- Filing discloses weighted average price $8.4885 and price range $8.15–$8.86
- Reporting person confirms willingness to provide per-trade price details on request
Negative
- None.
Insights
TL;DR: Director bought 15,000 shares at a weighted average $8.4885 on 08/18/2025; routine open-market insider purchase.
The Form 4 documents an open-market acquisition totaling 15,000 common shares at a reported weighted average price of $8.4885, with trade prices between $8.15 and $8.86. The filing shows the reporter is a director and the transaction was executed on 08/18/2025. The disclosure indicates the reporting person will provide per-trade pricing if requested, which clarifies the weighted average notation. From a reporting and valuation perspective, the entry is straightforward and provides clear quantitative detail on the director's incremental stake.
TL;DR: Director-level open market purchase disclosed; Form 4 properly reports beneficial ownership change and price range.
The filing identifies Robert Wills as a director and reports the acquisition method as open market purchases. The Form 4 lists the total shares acquired and the beneficially owned shares following the transaction, and includes the mandated statement offering to supply trade-by-trade prices on request. The document complies with Section 16 reporting norms by disclosing transaction date, aggregate amount, and weighted average price, with a manual signature dated 08/20/2025.
FAQ
What transaction did Alpha Cognition (ACOG) director Robert Wills report?
At what price did the insider purchases occur for ACOG?
How many shares does the reporting person beneficially own after the transaction?
When was the Form 4 transaction dated and when was it signed?
Did the Form 4 indicate the purchase method or any special plan?